Genomic And Proteomic Tool Market Report 2026
Genomic And Proteomic Tool Market Report 2026
Global Outlook – By Product Type (Instruments, Consumables, Software, ServicesBy Technology (Sequencing, Microarray, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, Chromatography), By Workflow Stage (Sample Preparation, Library Preparation, Data Analysis, Reporting), By Application (Drug Discovery, Diagnostics, Personalized Medicine, Agriculture And Animal Research), By End User (Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Healthcare Providers) – Market Size, Trends, Strategies, and Forecast to 2035
Genomic And Proteomic Tool Market Overview
• Genomic And Proteomic Tool market size has reached to $33.14 billion in 2025 • Expected to grow to $56.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.4% • Growth Driver: Surge In Personalized Medicine Fueling The Growth Of The Market Due To Advances In Genomics, Proteomics, And Biomarker-Based Tailored Treatments • Market Trend: Advancing Discovery Through Spatial Multi-Omics Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.
What Is Covered Under Genomic And Proteomic Tool Market?
Genomic and proteomic tools are a collection of advanced techniques and technologies used to study the complete set of genes (genome) and proteins (proteome) in an organism. Genomic tools focus on analyzing DNA and RNA to understand gene sequences, expression patterns, mutations, and interactions, using methods such as DNA sequencing, PCR, microarrays, and genome editing. Proteomic tools, on the other hand, examine the structure, function, abundance, and interactions of proteins through approaches such as mass spectrometry, 2D gel electrophoresis, and protein microarrays. The main product types of genomic and proteomic tools are instruments, consumables, software, and services. Instruments are purpose-built devices that measure, detect, separate, or manipulate physical or molecular properties in laboratory samples, enabling precise observation and control that human senses alone cannot achieve, across disciplines from microscopy to analytical measurement. The various technologies involved are sequencing, microarray, polymerase chain reaction (pcr), chromatography, which works by sample preparation, library preparation, data analysis, and reporting stages. The various applications involved are drug discovery, diagnostics, personalized medicine, agriculture, and animal research.
What Is The Genomic And Proteomic Tool Market Size and Share 2026?
The genomic and proteomic tool market size has grown rapidly in recent years. It will grow from $33.14 billion in 2025 to $37 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to rising genomic research funding, expansion of NGS technologies, growth in pharmaceutical R&D, increasing academic research activities, declining sequencing costs.What Is The Genomic And Proteomic Tool Market Growth Forecast?
The genomic and proteomic tool market size is expected to see rapid growth in the next few years. It will grow to $56.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to growth of precision medicine, increasing clinical genomics adoption, rising demand for proteomics in drug discovery, expansion of personalized diagnostics, advancements in bioinformatics tools. Major trends in the forecast period include high-throughput sequencing adoption, integrated multi-omics platforms, automation in sample preparation, growth of cloud-based bioinformatics, expansion of biomarker discovery.Global Genomic And Proteomic Tool Market Segmentation
1) By Product Type: Instruments, Consumables, Software, Services 2) By Technology: Sequencing, Microarray, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, Chromatography 3) By Workflow Stage: Sample Preparation, Library Preparation, Data Analysis, Reporting 4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Agriculture And Animal Research 5) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Healthcare Providers Subsegments: 1) By Instruments: DNA Sequencing Systems, Polymerase Chain Reaction (PCR) Systems, Microarray Analyzers, Mass Spectrometry Instruments, Electrophoresis Systems, Chromatography Instruments, Flow Cytometers 2) By Consumables: Reagents And Kits, Assay Kits, Sample Preparation Consumables, Sequencing Consumables, Protein Assay Reagents, Microarray Chips, Laboratory Chemicals 3) By Software: Genomic Data Analysis Software, Proteomic Data Analysis Software, Bioinformatics Platforms, Clinical Data Interpretation Tools, Workflow Management Software, Cloud-based Analysis Platforms 4) By Services: Next-Generation Sequencing (NGS) Services, Gene Expression And Genotyping Services, Protein Identification And Quantification Services, Biomarker Discovery Services, Structural Biology Analysis Services, Bioinformatics And Data Interpretation Services, Molecular Diagnostics ServicesWhat Is The Driver Of The Genomic And Proteomic Tool Market?
The increasing adoption of personalized medicine is expected to propel the growth of the genomic and proteomic tool market going forward. Personalized medicine is the tailoring of prevention, diagnosis, and treatment to an individual’s molecular profile using biomarkers derived from deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins. The increasing adoption of personalized medicine is due to advances in genomics, proteomics, and biomarker discovery, which enable tailored treatments based on individual genetic profiles, driving demand for targeted therapies, improved diagnostics, and precision healthcare solutions. Advances in genomics, proteomics, and biomarker discovery have enabled the development of targeted therapies and more accurate diagnostics based on a patient’s genetic profile. Genomic and proteomic tools play a crucial role in this process by identifying genetic variations and protein biomarkers, allowing clinicians to optimize treatments and improve patient outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the USFDA approved 16 new personalized treatments for rare disease patients in 2023, a significant increase from 6 personalized treatments in 2022. Therefore, the increasing adoption of personalized medicine is driving the genomic and proteomic tool industry.Key Players In The Global Genomic And Proteomic Tool Market
Major companies operating in the genomic and proteomic tool market are F. HoffmannLa Roche, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega, Novogene Corp., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Sophia Genetics, LC SciencesGlobal Genomic And Proteomic Tool Market Trends and Insights
Major companies operating in the genomic and proteomic tools market are focusing on innovation through spatial multi-omics technologies, which enable same-cell, in-situ detection of RNA and proteins to integrate molecular data layers, preserve tissue architecture, and accelerate discovery. Spatial multi-omics involves measuring gene expression and protein markers simultaneously within intact tissue at single-cell or subcellular resolution, offering richer biological insights than single-modality assays. For instance, in August 2025, 10x Genomics, a U.S.-based biotechnology company, introduced Xenium Protein, a first-of-its-kind assay for single-cell RNA and protein analysis on the Xenium in situ platform. This solution delivers a seamless, single-instrument workflow eliminating the need for cross-platform data integration and comes with validated, ready-to-use protein subpanels to simplify setup and quality control. These advancements allow researchers to maintain spatial context while expanding biomarker panels for applications such as target validation, patient stratification, and mechanism-of-action studies.What Are Latest Mergers And Acquisitions In The Genomic And Proteomic Tool Market?
In July 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Olink Holding AB for an undisclosed amount. This acquisition enhances Thermo Fisher’s next-generation proteomics portfolio by integrating Olink’s proximity extension assay (PEA) platform into its Life Sciences Solutions segment. The move strengthens the company’s capabilities in high-plex protein biomarker discovery and quantification, complementing its existing mass spectrometry and sequencing technologies, while accelerating advancements in translational research and companion diagnostic development. Olink Holding AB is a Sweden-based provider of next-generation proteomics tools and solutions.Regional Outlook
North America was the largest region in the genomic and proteomic tool market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Genomic And Proteomic Tool Market?
The genomic and proteomic tool market consists of revenues earned by entities by providing services such as DNA sequencing systems, gene expression analysis platforms, microarray technologies, and mass spectrometry systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic and proteomic tools market also includes sales of electrophoresis equipment, and chromatography instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Genomic And Proteomic Tool Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $37 billion |
| Revenue Forecast In 2035 | $56.95 billion |
| Growth Rate | CAGR of 11.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Technology, Workflow Stage, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | F. HoffmannLa Roche, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega, Novogene Corp., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Sophia Genetics, LC Sciences |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Genomic And Proteomic Tool Market Report 2026 market was valued at $33.14 billion in 2025, increased to $37 billion in 2026, and is projected to reach $56.95 billion by 2030.
request a sample hereThe expected CAGR for the Genomic And Proteomic Tool Market Report 2026 market during the forecast period 2025–2030 is 11.4%.
request a sample hereMajor growth driver of the market includes: Surge In Personalized Medicine Fueling The Growth Of The Market Due To Advances In Genomics, Proteomics, And Biomarker-Based Tailored Treatments in the Genomic And Proteomic Tool Market Report 2026 market. For further insights on this market,
request a sample hereThe genomic and proteomic tool market covered in this report is segmented –
1) By Product Type: Instruments, Consumables, Software, Services
2) By Technology: Sequencing, Microarray, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, Chromatography
3) By Workflow Stage: Sample Preparation, Library Preparation, Data Analysis, Reporting
4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Agriculture And Animal Research
5) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Healthcare Providers Subsegments:
1) By Instruments: DNA Sequencing Systems, Polymerase Chain Reaction (PCR) Systems, Microarray Analyzers, Mass Spectrometry Instruments, Electrophoresis Systems, Chromatography Instruments, Flow Cytometers
2) By Consumables: Reagents And Kits, Assay Kits, Sample Preparation Consumables, Sequencing Consumables, Protein Assay Reagents, Microarray Chips, Laboratory Chemicals
3) By Software: Genomic Data Analysis Software, Proteomic Data Analysis Software, Bioinformatics Platforms, Clinical Data Interpretation Tools, Workflow Management Software, Cloud-based Analysis Platforms
4) By Services: Next-Generation Sequencing (NGS) Services, Gene Expression And Genotyping Services, Protein Identification And Quantification Services, Biomarker Discovery Services, Structural Biology Analysis Services, Bioinformatics And Data Interpretation Services, Molecular Diagnostics Services
request a sample here1) By Product Type: Instruments, Consumables, Software, Services
2) By Technology: Sequencing, Microarray, Polymerase Chain Reaction (PCR), Mass Spectrometry, Electrophoresis, Chromatography
3) By Workflow Stage: Sample Preparation, Library Preparation, Data Analysis, Reporting
4) By Application: Drug Discovery, Diagnostics, Personalized Medicine, Agriculture And Animal Research
5) By End User: Academic And Research Institutions, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Healthcare Providers Subsegments:
1) By Instruments: DNA Sequencing Systems, Polymerase Chain Reaction (PCR) Systems, Microarray Analyzers, Mass Spectrometry Instruments, Electrophoresis Systems, Chromatography Instruments, Flow Cytometers
2) By Consumables: Reagents And Kits, Assay Kits, Sample Preparation Consumables, Sequencing Consumables, Protein Assay Reagents, Microarray Chips, Laboratory Chemicals
3) By Software: Genomic Data Analysis Software, Proteomic Data Analysis Software, Bioinformatics Platforms, Clinical Data Interpretation Tools, Workflow Management Software, Cloud-based Analysis Platforms
4) By Services: Next-Generation Sequencing (NGS) Services, Gene Expression And Genotyping Services, Protein Identification And Quantification Services, Biomarker Discovery Services, Structural Biology Analysis Services, Bioinformatics And Data Interpretation Services, Molecular Diagnostics Services
Major trend in this market includes: Advancing Discovery Through Spatial Multi-Omics Innovation For further insights on this market,
request a sample hereMajor companies operating in the Genomic And Proteomic Tool Market Report 2026 market are Major companies operating in the genomic and proteomic tool market are F. HoffmannLa Roche, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., PerkinElmer Inc., Promega, Novogene Corp., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Sophia Genetics, LC Sciences
request a sample hereNorth America was the largest region in the genomic and proteomic tool market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic and proteomic tool market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here